Cargando…
A systems approach delivers a functional microRNA catalog and expanded targets for seizure suppression in temporal lobe epilepsy
Temporal lobe epilepsy is the most common drug-resistant form of epilepsy in adults. The reorganization of neural networks and the gene expression landscape underlying pathophysiologic network behavior in brain structures such as the hippocampus has been suggested to be controlled, in part, by micro...
Autores principales: | Venø, Morten T., Reschke, Cristina R., Morris, Gareth, Connolly, Niamh M. C., Su, Junyi, Yan, Yan, Engel, Tobias, Jimenez-Mateos, Eva M., Harder, Lea M., Pultz, Dennis, Haunsberger, Stefan J., Pal, Ajay, Heller, Janosch P., Campbell, Aoife, Langa, Elena, Brennan, Gary P., Conboy, Karen, Richardson, Amy, Norwood, Braxton A., Costard, Lara S., Neubert, Valentin, Del Gallo, Federico, Salvetti, Beatrice, Vangoor, Vamshidhar R., Sanz-Rodriguez, Amaya, Muilu, Juha, Fabene, Paolo F., Pasterkamp, R. Jeroen, Prehn, Jochen H. M., Schorge, Stephanie, Andersen, Jens S., Rosenow, Felix, Bauer, Sebastian, Kjems, Jørgen, Henshall, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355001/ https://www.ncbi.nlm.nih.gov/pubmed/32581127 http://dx.doi.org/10.1073/pnas.1919313117 |
Ejemplares similares
-
Enrichment of Circular RNA Expression Deregulation at the Transition to Recurrent Spontaneous Seizures in Experimental Temporal Lobe Epilepsy
por: Gomes-Duarte, Andreia, et al.
Publicado: (2021) -
Potent Anti-seizure Effects of Locked Nucleic Acid Antagomirs Targeting miR-134 in Multiple Mouse and Rat Models of Epilepsy
por: Reschke, Cristina R., et al.
Publicado: (2017) -
Long non‐coding RNAs in motor neuron development and disease
por: Vangoor, Vamshidhar R., et al.
Publicado: (2020) -
Brain cell-specific origin of circulating microRNA biomarkers in experimental temporal lobe epilepsy
por: Brindley, Elizabeth, et al.
Publicado: (2023) -
Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy
por: Reschke, Cristina R., et al.
Publicado: (2021)